by Wei Liu, Ph.D. | Aug 22, 2019 | Blog
Wei Liu, Ph.D. FollowFollowFollow The KRAS gene is one of the major oncogenes whose mutations can lead to different types of cancer. KRAS, along with other RAS genes, NRAS and HRAS, is a RAS gene family member in the RAS/MAPK signal pathway that passes the signal from...
by Wei Liu, Ph.D. | Apr 18, 2019 | Blog
Wei Liu, Ph.D. FollowFollowFollow HPV Can Lead to Different Types of Cancer at Different SitesHuman papillomavirus (HPV) is mostly transmitted through sexual activities. Most of the infection (90%) is transient and the virus becomes undetectable within two years. The...
by Wei Liu, Ph.D. | Jan 31, 2019 | Blog
Wei Liu, Ph.D. FollowFollowFollow Liquid biopsy gains traction as a powerful minimally invasive sampling method. Circulating cell-free DNA (cfDNA) is often analyzed from liquid biopsy samples for molecular diagnostics. cfDNA is small DNA fragments found free-floating...
by Wei Liu, Ph.D. | Nov 15, 2018 | Blog
Wei Liu, Ph.D. FollowFollowFollow Is it necessary to confirm variants from NGS?Next-generation sequencing (NGS) is a powerful tool that has seen a fast increase in clinical labs although only a few NGS tests have been approved by the FDA. However, there have been a...
by Wei Liu, Ph.D. | Oct 9, 2018 | Blog
Wei Liu, Ph.D. FollowFollowFollow Common EGFR Mutations in Non-Small Cell Lung CancerEighty five percent of the lung cancer patients are non-small cell lung cancer (NSCLC) patients. Among this population, patients with exon 19 deletion and L858R mutations respond well...
